Category: Biolase Technology Inc.
Biolase ties the bow on a $5 million private placement with Oracle Investment Management it plans to use to pay down debt.
Biolase (NSDQ:BIOL) said it closed a $5 million private placement with Oracle Investment Management.
The surgical laser maker sold off a little more than 1.9 million shares for $2.57 each, with the deal closing on Feb. 10. The money is expected to go toward paying down its $4.6 million credit facility with Comerica Bank, according to chairman & CEO Federico Pignatelli .
Medical lasers maker Biolase adds 2 new directors to its board and engages Piper Jaffray & Co. as its exclusive financial advisor as it continues to evaluate a potential sale.
Biolase shares tank after the medical device company reports gaping 3rd-quarter losses and sacks its sales vice presidents, saying it will court a potential acquirer.
Biolase and Auris Surgical Robotics ink a deal to co-develop a cataract-removal ophthalmological robot.
Biolase (NSDQ:BIOL) and Auris Surgical Robotics said they've inked a deal to collaborate on developing a cataract-removal ophthalmologic robot.
A group of Biolase shareholders are suing in a class action lawsuit accusing company directors of lying about its financial struggles.
Biolase (NSDQ:BLTI) is facing a lawsuit brought by shareholders accusing the company of hiding problems by lying on quarterly earnings reports. The lawsuit claims Biolase and its directors concealed liquidity and solvency issues as well as under-performing sales.
Martha Shadan, a former executive for the likes of Zimmer and Covidien, will take the reins at young orthotics company Rotation Medical.
Minnesota-based orthotics company Rotation Medical appointed Martha Shadan as the new president & CEO.
Second Sight Medical registers for a $10 million funding round to back its Argus II 'bionic eye' retinal implant.
Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market.
The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina.